Abstract:The surge in demand for experimental monkeys has led to a rapid increase in their associated costs. Consequently, there is a growing need for the development of a cost-effective model for Parkinson’s disease (PD) that exhibits all core clinical and pathological phenotypes of PD. Evolutionarily, tree shrews ( Tupaia belangeri ) are much closer to primates in comparison to rodents and share more similar PD-related brain structures and movement ability with monkeys. As such, tree shrews represent an ideal small animal species for modeling PD. To develop a tree shrew PD model, we used the 1-Methyl-4-phenylpyridinium (MPP+) metabolite, derived from the well-established PD modeling drug 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), to induce lesions in the dopaminergic neurons of the unilateral substantia nigra. After determining the optimal modeling dosage, the tree shrews consistently exhibited and maintained all classic clinical manifestations of PD for a 5-month period. The symptoms closely resembled the ones observed in PD monkeys and included bradykinesia, rest tremor, postural instability, and apomorphine-induced rotations, a classic phenotype of unilateral PD models. Immunostaining showed a significant loss of dopaminergic neurons (approximately 95%) in the substantia nigra on the lesioned side of the brain, a crucial pathological marker of PD. Further cytomorphological analysis revealed that the size of nigral dopaminergic neurons in tree shrews exceeded that of rodents and more closely approximated that of macaques. Based on the principle that structure determines function, the morphological similarity between tree shrews and monkeys may be an important structural basis for the manifestation of the highly similar phenotypes between monkey and tree shrew PD models. Collectively, this study successfully developed a PD model in a small animal species that faithfully recapitulated the classical clinical symptoms and key pathological indicators of PD monkeys. In addition to the well-recognized monkey models, the tree shrew model provides a novel avenue for the evaluation of PD treatments and underlying mechanisms.### Competing Interest StatementThe authors have declared no competing interest.

Cognitive Deficits and Alzheimer's Disease-Like Pathologies in the Aged Chinese Tree Shrew.

Does the Genetic Feature of the Chinese Tree Shrew (Tupaia belangeri chinensis) Support Its Potential as a Viable Model for Alzheimer's Disease Research?

Alpha-synuclein is highly prone to distribution in the hippocampus and midbrain in tree shrews, and its fibrils seed Lewy body-like pathology in primary neurons.

Age-related changes in brain metabolites and cognitive function in APP/PS1 transgenic mice.

Age-related changes in hippocampal AD pathology, actin remodeling proteins and spatial memory behavior of male APP/PS1 mice.

Human and Tree Shrew Alpha-synuclein: Comparative Cdna Sequence and Protein Structure Analysis

Study of tree shrew biology and models: A booming and prosperous field for biomedical research

New Tree Shrew Parkinson’s Model: a Cost-Effective Alternative to Monkey Models

A nonhuman primate model with Alzheimer's disease-like pathology induced by hippocampal overexpression of human tau

Depicting Primate-Like Granular Dorsolateral Prefrontal Cortex in the Chinese Tree Shrew

Characterization of the APP/PS1 Mouse Model of Alzheimer's Disease in Senescence Accelerated Background

A Non-Human Primate Model with Alzheimer's Disease-Like Pathology Induced by Hippocampal Overexpression of Human Tau

Effects of Accelerated Senescence on Learning and Memory, Locomotion and Anxiety-Like Behavior in APP/PS1 Mouse Model of Alzheimer's Disease

Alzheimer disease-like neuropathologic changes in a geriatric baboon (Papio hamadryas)

Dynamic changes in lysosome-related pathways in APP/PS1 mice with aging

Genome of the Chinese Tree Shrew

The Tree Shrew Model of Parkinson Disease: A Cost-Effective Alternative to Nonhuman Primate Models

Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study

Temporal Alterations in White Matter in An App Knock-In Mouse Model of Alzheimers Disease

Astroglial atrophy associates with loss of nuclear S100A10 in the hippocampus of aged male tree shrews

Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease